Recent in Updates by Region (page 8 of 12)

W.S. Badger Recalls Baby/Kids Sunscreen Due to Compromised Preservatives

W.S. Badger Co. Inc. is voluntarily recalling all lots of its 4-ounce SPF 30 Baby Sunscreen Lotion and one lot of its 4-ounce SPF 30 Kids Sunscreen Lotion due to microbial contamination that stems from a compromised preservative system.

The EU's Proposed 8th Amendment

Just as the industry began to comply with the 7th Amendment to the Cosmetic Directive, the European Union (EU) Commission proposed the new 8th Amendment. After confusion surrounding the old rules, the commission attempted to correct matters, only making them worse.

Regulations in ASEAN Countries

The Association of Southeast Asian Nations (ASEAN) has agreed to harmonize its cosmetic regulatory scheme.

Regulatory Review: Australian Regulations Update

Australia issued its new Cosmetics Standard 2007. The following is a breakdown of products originally considered as therapeutic drugs if they made SPF claims, and that will now be regulated as secondary sunscreens.

EU Regulation No. 1223/2009, Part III: The Responsible Person

This column is the last in a three- part series on the European Union’s (EU) Regulation No. 1223/2009,1 which was published on Dec. 22, 2009.

When Ingredient Alarm Leads to the Courtroom

The personal care industry has experienced growing consumer interest in the ingredients its products contain. This interest has resulted in better responsibility and safety among cosmetic manufacturers; however, it also has produced elevated concerns over potentially harmful ingredients.

The Future of Hair Dyes Under the New EU Regulation: A Discussion

The “recast” of the 1976 Cosmetics Directive was intended to make things simpler, but does it? This article reviews and comments on the EU’s regulatory position on hair dyes, as of the first half of 2013.

Kanebo Recalls Brightening Products Containing Rhododenol

Kanebo Cosmetics Inc. and its affiliates Lissage Ltd. and E’quipe, Ltd. have recalled brightening products from the Japanese market containing the quasi-drug ingredient rhododenol (4-(4-hydroxyphenyl)-2-butanol).

The Future of Hair Dyes Under the New EU Regulation: A Discussion

The “recast” of the 1976 Cosmetics Directive was intended to make things simpler, but does it? This article reviews and comments on the EU’s regulatory position on hair dyes, as of the first half of 2013.

FDA Publishes its Draft Guidance for Cosmetic GMPs

The U.S. Food and Drug Administration (FDA) has published its Draft Guidance for Cosmetic Good Manufacturing Practices (GMPs), an update to its Cosmetic Good Manufacturing Guidelines/Inspection Checklist, mostly to include ISO 227 16:2007 as part of an effort to harmonize GMPs internationally.

Cosmetics Registration in California and the FDA's Electronic-only Drug Registration

The stars where poorly aligned on June 15, 2009, when California finally issued its registration procedure and forms for the California Safe Cosmetics Act of 2005. At the same time, the US Food and Drug Administration (FDA) moved to an electronic-only filing system for drug registrations. These two changes have created significantly more work for the personal care industry—and with questionable benefits.

Recent ATPs and Their Effect in the EU and Abroad

The recast of the directive, known as the 8th Amendment, has been proposed. This amendment currently is in review by the European Parliament and Council of Ministers. If an agreement is reached, the personal care industry will see many sweeping changes, as reported in the June 2008 edition of this column.

Can't find what you're looking for? Try searching, or looking through past issues.